Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2)

Pediatric Neurology
Andrea L GropmanAnn C M Smith

Abstract

The Smith-Magenis syndrome is a rare, complex multisystemic disorder featuring, mental retardation and multiple congenital anomalies caused by a heterozygous interstitial deletion of chromosome 17p11.2. The phenotype of Smith-Magenis syndrome is characterized by a distinct pattern of features including infantile hypotonia, generalized complacency and lethargy in infancy, minor skeletal (brachycephaly, brachydactyly) and craniofacial features, ocular abnormalities, middle ear and laryngeal abnormalities including hoarse voice, as well as marked early expressive speech and language delays, psychomotor and growth retardation, and a 24-hour sleep disturbance. A striking neurobehavioral pattern of stereotypies, hyperactivity, polyembolokoilamania, onychotillomania, maladaptive and self-injurious and aggressive behavior is observed with increasing age. The diagnosis of Smith-Magenis syndrome is based upon the clinical recognition of a constellation of physical, developmental, and behavioral features in combination with a sleep disorder characterized by inverted circadian rhythm of melatonin secretion. Many of the features of Smith-Magenis syndrome are subtle in infancy and early childhood, and become more recognizable with advancing ...Continue Reading

References

Sep 1, 1991·Journal of Medical Genetics·A MonclaF Giraud
Jul 1, 1986·American Journal of Medical Genetics·A C SmithE Magenis
Sep 1, 1993·European Journal of Pediatrics·C GuilleminaultM Cetel
Mar 29, 1996·American Journal of Medical Genetics·F GreenbergJ R Lupski
Jun 5, 1998·American Journal of Medical Genetics·A C SmithF Greenberg
Nov 11, 1998·Journal of the American Academy of Child and Adolescent Psychiatry·F E Crumley
Feb 25, 1999·Journal of Intellectual Disability Research : JIDR·E M Dykens, A C Smith
Apr 13, 2000·Journal of the American Academy of Child and Adolescent Psychiatry·R GruberA Raviv
Jun 14, 2000·Journal of Medical Genetics·L PotockiJ R Lupski
Feb 24, 2001·American Journal of Medical Genetics·E L GouldR M Huggins
Mar 15, 2001·American Journal of Mental Retardation : AJMR·B FinucaneE W Simon
May 30, 2001·International Journal of Pediatric Otorhinolaryngology·M Di CiccoA Selicorni
Mar 26, 2003·Nature Genetics·Rebecca E SlagerSarah H Elsea
Nov 14, 2003·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Lorraine PotockiJames R Lupski
Sep 13, 2005·Clinical Dysmorphology·Lisbeth MarianneJensen, Maria Kirchhoff
Mar 30, 2006·Journal of Autism and Developmental Disorders·Staci C MartinAnn C M Smith
Apr 29, 1966·Science·H P RoffwargW C Dement

❮ Previous
Next ❯

Citations

May 7, 2011·Expert Reviews in Molecular Medicine·Sarah H Elsea, Stephen R Williams
Oct 8, 2009·European Journal of Human Genetics : EJHG·Bregje W M van BonBert B A de Vries
Jan 31, 2008·European Journal of Human Genetics : EJHG·Sarah H Elsea, Santhosh Girirajan
Jun 13, 2012·The Primary Care Companion to CNS Disorders·Brandon T UnruhTheodore A Stern
Oct 22, 2009·Physical & Occupational Therapy in Pediatrics·Michaele R SmithAnn C M Smith
May 15, 2012·European Journal of Medical Genetics·Ana OsórioMontse Fernández-Prieto
Dec 22, 2015·American Journal of Medical Genetics. Part a·Elizabeth EvansStewart Einfeld
Sep 15, 2009·Pediatric Neurology·Pamela L WoltersAnn C M Smith
Dec 18, 2015·Indian Journal of Pediatrics·Rekha GuptaShubha R Phadke
Oct 29, 2010·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Gonzalo LajeAnn C M Smith
Oct 29, 2010·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Gonzalo LajeAnn C M Smith
Jul 9, 2011·American Journal of Medical Genetics. Part a·Philip M BooneLorraine Potocki
May 25, 2013·American Journal of Medical Genetics. Part a·Melanie LacariaJames R Lupski
Feb 13, 2013·Journal of Cutaneous Pathology·Jennifer M ReeseAdam I Rubin
Feb 27, 2010·American Journal of Medical Genetics. Part a·Chiara LeoniGiuseppe Zampino
Feb 17, 2015·Pediatric Dermatology·Morgane Guérin-MoreauLudovic Martin
Sep 5, 2015·Orphanet Journal of Rare Diseases·Alice PoissonCaroline Demily
Jun 26, 2012·Developmental Neurorehabilitation·Christa EinspielerPeter B Marschik
May 24, 2011·Physical & Occupational Therapy in Pediatrics·Hanna L Hildenbrand, Ann C M Smith
Jun 15, 2015·Seminars in Pediatric Neurology·Thomas J DyeSanjeev V Kothare
May 3, 2015·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·A PoissonC Demily
Sep 10, 2014·Research in Developmental Disabilities·Elena Garayzábal HeinzeAdriana Sampaio
Sep 30, 2016·American Journal of Medical Genetics. Part a·Fabio AcquavivaGioacchino Scarano
Dec 22, 2016·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Matthias W WagnerThierry A G M Huisman
Apr 28, 2017·Biology·Nalini R RaoKatherina Walz
May 14, 2017·Journal of Autism and Developmental Disorders·Lucy Wilde, Chris Oliver
Aug 1, 2018·International Journal of Molecular Sciences·Stephen C Bondy, Arezoo Campbell
Sep 28, 2018·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·H ReddonD Meyre
Mar 14, 2007·Current Opinion in Neurology·Andrea L GropmanAnn C M Smith
Apr 7, 2017·Journal of Speech, Language, and Hearing Research : JSLHR·Megan A BrendalAnn C M Smith
Dec 18, 2018·Current Opinion in Psychiatry·Brian J Shayota, Sarah H Elsea
Feb 28, 2008·Journal of Developmental and Behavioral Pediatrics : JDBP·Matthew HicksJean-François Lemay
May 3, 2019·Journal of Intellectual Disabilities : JOID·Heidi Elisabeth NagTerje Nærland
Jan 28, 2020·Journal of Intellectual Disabilities : JOID·Heidi Elisabeth Nag, Terje Nærland
Aug 23, 2019·Journal of Clinical Psychopharmacology·Samira S Khan, Taniya Pradhan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autism: Treatment Targets

The absence of effective treatments for autism are due to the high clinical and genetic heterogeneity between affected individuals, restricted knowledge of the underlying pathophysiological mechanisms, and the lack of reliable diagnostic biomarkers. Identification of more homogenous biological subgroups is therefore essential for the development of novel treatments based on the molecular mechanisms underpinning autism and autism spectrum disorders. Find the latest research on autism treatment targets here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.

Related Papers

Journal of Developmental and Behavioral Pediatrics : JDBP
Niru MadduriLorraine Potocki
Clinical Dysmorphology
Lisbeth MarianneJensen, Maria Kirchhoff
© 2022 Meta ULC. All rights reserved